tocilizumaberlotinibMEK inhibitorsNeurofibromatosis type 1 (NF1)
… high-affinity FDA-approved inhibitors for IL6R and EGFR (e.g., tocilizumab and erlotinib), as well as PAM analogs targeting mGluR7. Logic …
1articles mentioning drugs
1drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: MEK inhibitors ×
MEK inhibitors
This drug is selected. Its supporting articles are shown below.